Zynerba
Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program
ZYN001 is a synthetic pro‑drug of THC in a state-of-the-art drug-adhesive … ZYN002, the Company's CBD gel, is the first and only…
Better Know a Marijuana Stock: Zynerba Pharmaceuticals
However, there are dozens of marijuana stocks for investors to choose from. … For those who may not recall, an oral CBD-based…
Maxim Group Starts Zynerba Pharmaceuticals (ZYNE) at Buy
2017 could be a transformational year for Zynerba, as three ongoing phase II trials for lead cannabis-based candidate, ZYN002 cannabidiol (CBD) gel ……
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) One of the More Legit Marijuana Companies
ZYN002 CBD gel is the first and only patent-protected, synthetic CBD that is formulated as a permeation-enhanced gel for transdermal delivery….
Zynerba Thesis Continues To Play Out As Management Executes
… psychoactive effects, GI distress, and reducing drug interactions patients and doctors would be more likely to prefer ZYN002 over oral CBD…
Best Stocks of 2017: Zynerba Pharmaceuticals Inc (ZYNE) Stock Is a Perfect Prescription
This is the cleaner side of marijuana. … defining compounds, cannabinoid (CBD) and tetrahydrocannabinol (THC), then deliver to them to patients as…